top of page
News, Events and Updates
Search
Anavex Life Sciences to Announce Fiscal 2021 First Quarter Financial Results and Business Outlook
Feb 8, 2021
Anavex Life Sciences Receives Michael J. Fox Foundation Grant for Clinical Study of ANAVEX®2-73
Jan 11, 2021
Anavex Life Sciences to Present at the H.C. Wainwright Virtual BioConnect Conference
Jan 6, 2021
Anavex Life Sciences Reports Fiscal 2020 Year End Financial Results And Clinical Program Updates
Dec 28, 2020
Anavex Life Sciences to Announce Fiscal 2020 Year End Financial Results December 28th, 2020
Dec 22, 2020
Anavex Life Sciences Announces Webinar on Rett Syndrome and ANAVEX®2-73 (Blarcamesine) Phase 2 Data
Dec 21, 2020
Anavex Life Sciences Announces ANAVEX®2-73 Meets Primary and Secondary Endpoints in Clinical Trial
Dec 15, 2020
Anavex Life Sciences Announces Notice of Allowance for U.S. Patent Application with Expanding Claims
Nov 30, 2020
Anavex Life Sciences to Present at the Evercore ISI 3rd Annual HealthCONx Conference
Nov 25, 2020
Anavex Life Sciences Presents Proof of Concept Controlled Phase 2 Clinical Trial Data
Nov 6, 2020
Anavex Life Sciences Announces Positive Results from Proof of Concept controlled Phase 2 Trial
Oct 14, 2020
14
15
16
17
18
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
